Fibroblast Growth Factor-1

FGF-1 · CardioVascular BioTherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fibroblast Growth Factor-1, covering 2019-11-01 to 2019-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease [Phase 2]